Accessibility Menu
Kewaunee Scientific logo

Kewaunee Scientific

(NASDAQ) KEQU

Current Price$37.66
Market Cap$108.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1985)+466%
5 Year+184%
1 Year-35%
1 Month+1%
Kewaunee Scientific last closing stock price
MetricPriceDate
Last closeUSD 37.712026-07-16
Kewaunee Scientific stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.63%USD 35.702026-07-09
1 month+0.56%USD 37.502026-06-16
3 month+2.75%USD 36.702026-04-17
Year to date+0.8%USD 37.412025-12-31
1 year-35.38%USD 58.362025-07-16
3 year+157.06%USD 14.672023-07-17
5 year+183.96%USD 13.282021-07-16
Since inception+466.41%USD 6.661985-02-19

Kewaunee Scientific Financials at a Glance

Market Cap

$108.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$282.00M

Net Income (TTM)

$9.62M

EPS (TTM)

$3.22

P/E Ratio

11.69

Dividend

$0.00

Beta (Volatility)

0.47 (Low)

Price

$37.66

Volume

2,817

Open

$36.95

Previous Close

$37.71

Daily Range

$36.95 - $38.06

52-Week Range

$33.27 - $60.89

Estimated Earnings Date

Sep 16, 2026

KEQU News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kewaunee Scientific

Kewaunee makes furniture and equipment for laboratories and healthcare spaces. Its products help scientists, doctors, and students work safely and efficiently. For example, fume hoods protect users from hazardous fumes, while workstations organize tools and samples.

Lab Life, Simplified: Products and Services

  • Laboratory Furniture: Steel, wood, and laminate benches and cabinets for labs in schools, hospitals, and industry.
  • Fume Hoods: Enclosures that remove hazardous fumes, used in chemistry and biology labs.
  • Biological Safety Cabinets: Equipment that protects users and samples from contamination, mainly for healthcare and research labs.
  • Modular Systems: Flexible workstations and carts for changing lab needs and layouts.
  • Epoxy Worksurfaces and Sinks: Durable surfaces and sinks for handling chemicals and cleaning in labs.
  • Design Services: Planning and project management for new or renovated laboratory spaces.

Growth Spurts: Expansion and Acquisitions

  • Acquired Nu Aire in November 2024, adding biological safety cabinets and airflow products.
  • Expanded product lines to include CO2 incubators and ultralow freezers after 2024.
  • Increased international sales, which were approximately 23.6% of total sales for the quarter ended July 31, 2025.
  • Invested in technology and processes to support growth since 2024.
  • Launched a share repurchase program, with 100,603 shares still authorized as of July 2025.

What Makes Kewaunee Stand Out

Kewaunee serves both domestic and international markets through dealers, subsidiaries, and a national distributor. Its broad product range covers furniture, safety equipment, and design services for labs and healthcare. The company’s integrated approach helps clients set up safe, efficient workspaces from start to finish.

Five Things You Need to Know

  • Revenue was $70 million in QQ2 2026, up 46.8% year-over-year.
  • Gross profit margin reached 29.4% in the three months ended July 31, 2025, up from 25.8% in the same period last year.
  • Domestic sales made up 76.5% of total in July 2025; international, 23.5%.
  • Order backlog was $205 million at July 31, 2025, up from $159.4 million year-over-year.
  • Net income was $2 million in QQ2 2026, down 18.7% year-over-year.

Bottom Line

Kewaunee has grown by expanding its product range and entering new markets. Its focus on lab safety and efficiency supports steady demand across science, healthcare, and education.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Employees

1,231

CEO

Thomas D. Hull, III, MBA

Headquarters

Statesville, NC 28677-2927, US

KEQU Financials

Key Financial Metrics (TTM)

Gross Margin

28.52%

Operating Margin

5.93%

Net Income Margin

3.41%

Return on Equity

13.63%

Return on Capital

15.93%

Return on Assets

5.39%

Earnings Yield

8.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$108.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.87M

Volume

2.82K

Avg. Volume

3.94K

Financials (TTM)

Gross Profit

$80.44M

Operating Income

$16.72M

EBITDA

$23.88M

Operating Cash Flow

$18.63M

Capital Expenditure

-$3.94M

Free Cash Flow

$14.70M

Cash & ST Invst.

$11.62M

Total Debt

$30.19M

Kewaunee Scientific Performance Analysis

Kewaunee Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30USD 219,494,00030.0%
20242024-04-30USD 203,755,000-7.2%
20252025-04-30USD 240,472,00018.0%
20262026-04-30USD 281,999,00017.3%
Kewaunee Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-31-7.8%
Q22025-10-31-1.4%
Q32026-01-31-1.0%
Q42026-04-302.9%
Kewaunee Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30USD 0.25N/A
20242024-04-30USD 6.382410.0%
20252025-04-30USD 3.83-40.0%
20262026-04-30USD 3.22-15.8%
Kewaunee Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-31-36.2%
Q22025-10-31-21.2%
Q32026-01-31-72.0%
Q42026-04-30391.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$71.40M

-7.5%

Gross Profit

$21.25M

-11.6%

Gross Margin

29.75%

N/A

Market Cap

$108.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$87.87K

N/A

Employees

1,231

N/A

Net Income

$3.39M

-30.1%

EBITDA

$6.94M

-29.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$11.62M

-22.3%

Total Debt

$30.19M

-39.8%

Accounts Receivable

$58.74M

-5.8%

Inventory

$30.53M

-7.1%

Long Term Debt

$21.37M

-50.2%

Short Term Debt

$8.81M

+21.4%

Return on Assets

5.39%

N/A

Return on Invested Capital

12.86%

N/A

Free Cash Flow

$4.53M

-49.0%

Operating Cash Flow

$5.46M

-42.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PLBYPlayboy, Inc.
$1.20+8.11%
VIRCVirco Mfg. Corporation
$6.06+0.17%
CAASChina Automotive Systems, Inc.
$4.36-1.58%
HOFTHooker Furnishings Corporation
$14.20-4.51%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$27.51-0.12%
NOKNokia
$10.38-0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.74-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.89+0.05%

Questions About KEQU

What is the current price of Kewaunee Scientific?

Kewaunee Scientific is trading at $37.71 per share.

What is the 52-week range for Kewaunee Scientific?

Over the past 52 weeks, Kewaunee Scientific has traded between $33.27 and $60.89.

How much debt does Kewaunee Scientific have?

As of the most recent reporting period, Kewaunee Scientific reported total debt of $56.82M.

How much cash does Kewaunee Scientific have on hand?

Kewaunee Scientific reported $11.62M in cash and cash equivalents in its most recent financial results.

What is Kewaunee Scientific’s dividend yield?

Kewaunee Scientific does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.